[Effectiveness of non-pharmacological primary care methods for giving up tobacco dependency]
B Sanz Pozo1, J de Miguel Díaz, M Aragón Blanco
1Especialista en Medicina Familiar y Comunitaria, Centro de Salud El Greco, Area 10 de Madrid, Getafe, Madrid, España. bsanzpozo@hotmail.com
Objective:
To determine the effectiveness of a systematic and intensive programme of tobacco counselling, as against brief anti-tobacco counselling.
Design:
Controlled and randomised clinical trial.
Setting:
Primary care medical and nursing clinics at an urban Health Centre in Getafe.
Participants:
Smokers who request health care at the medical clinics for any reason during the recruitment period, who satisfy the inclusion criteria and who want to take part in the study. The inclusion criteria are: 18 years old or more, people who have smoked daily during the previous month any amount of cigarettes, and high motivation (score over 7 on the Richmond test).
Intervention:
The 110 patients recruited by each doctor will be included, depending on the clinic they come from, in the control group (brief counselling) or the intervention group (intensive counselling). For the patients in the intervention group, monitoring visits will be programmed for 6 months after giving up. Both groups will be called by phone after a year to see if they are still smoking.
Main Measurements:
Abstinence at 12 months. SECONDARY MEASUREMENTS: a) Recorded at the start: personal details, medical history and smoking history; b) recorded at the consultations: abstinence, date of first giving up and symptoms of withdrawal syndrome.
Discussion:
The study will define the role of nursing professionals in taking patients off tobacco and will help define the effectiveness of non-medical methods to achieve this.
More Related Videos
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Stress Prevention and Stress Management Techniques IV
